Albuquerque, NM, October 30, 2024 – The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), among the leading institutes for clinical digital pathology and research in the European Union, has partnered...

New from GE HealthCare: Innovations include Health Companion research project powered by agentic AI Additional early innovations explore pressing care needs, including identifying new ways to detect breast cancer and improving...

Results published in JCO Precision Oncology; pathologists supported by Ibex Breast HER2 show improvement in HER2 scoring accuracy and consistency BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in...

Utilizing Owkin’s expansive data network and cutting-edge AI, this solution optimizes pre-screening for gBRCA mutations in breast cancer directly from digitized H&E pathology slides The solution aims to improve gBRCA...

Nijmegen, the Netherlands – Aiosyn is proud to announce the first results of an independent clinical performance study conducted for its Aiosyn Mitosis Breast solution. This study was performed at Radboud University Medical Center...

Fimlab Laboratories Ltd has selected Aiforia Technologies Plc as the provider for breast and prostate cancer diagnostics solutions. Aiforia Technologies Plc, August 1, 2024 at 09:00 am EEST -- Fimlab Laboratories Ltd has selected Aiforia...